health pharma news today obesity drugs glp-1 today Once people understood glucagonlike peptide 1 (GLP-1) drugs' potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 Data Brief: GLP-1 Prescriptions for

The choice depends on medical advice, personal preference and how well the medication works for the individual

BMC Public Health 11(1):116 Ludvigsson JF, Almqvist C, Bonamy AKE et al (2016) Registers of the Swedish total population and their use in medical research

In their meta-analysis, Monami et al also considered the occurrence of any major cardiovascular event, a composite end point of CV death, stroke, nonfatal myocardial infarction, heart failure, or acute coronary syndrome

Patients may talk about Ozempic face, characterized by the loss of facial fat

A phase 2 trial assessing mazdutide 3, 4.5 and 6 mg in a Chinese population with overweight/obesity demonstrates up to 11.3% WL after 24 weeks of treatment compared to 1% weight gain with placebo [70]